Humana reports adjusted earnings of $7.61 per share, exceeding estimates of $7.22, as medical cost ratio holds at 91.2%.
Humana posted second-quarter adjusted earnings of $7.61 per share, surpassing analysts’ estimates of $7.22. The company’s medical cost ratio remained at 91.2%, aligning with expectations and easing investor concerns over rising healthcare expenses.
The insurer maintained its full-year profit forecast despite pressure on Medicare Advantage plans from higher costs and tighter reimbursement rates. Competitors like UnitedHealth have recently raised outlooks, lifting sector expectations.
Shares fell about 9% in premarket trading, reflecting investor caution over the unchanged annual guidance despite the earnings beat.